estrogen receptor positive breast cancer icd 10

Release time ：Dec-18,2024

Estrogen receptor-positive (ER+) breast cancer, classified under ICD-10, is a prevalent form of breast cancer defined by the presence of estrogen receptors on the tumor cell surface, suggesting that tumor growth may be estrogen-dependent. Therapies for this breast cancer subtype often involve medications that target the estrogen receptor, such as tamoxifen or aromatase inhibitors.

Treatment strategies for ER+ breast cancer are primarily contingent upon the tumor’s specific characteristics, including its size, grade, lymph node involvement, and the patient’s overall health. Generally, early-stage ER+ breast cancer has a more favorable prognosis and a wider array of treatment options. For early-stage patients, surgical tumor removal is typically performed, followed by a determination of the necessity for radiotherapy, chemotherapy, or endocrine therapy based on the individual case. In contrast, for patients with advanced or metastatic disease, treatment goals shift towards disease management and symptom palliation.

Regular medical check-ups and adherence to physician-recommended treatment plans are essential for patients with ER+ breast cancer. Additionally, maintaining a healthy lifestyle, including a balanced diet, regular exercise, and abstaining from smoking, can contribute to enhanced treatment efficacy and quality of life. It is imperative to remember that all treatments should be conducted under a physician's supervision and self-medication should be avoided.